Clinical Trial Update: Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine versus placebo for prevention of thrombotic relapse in primary antiphospholipid syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Angers | Conditions: Primary Antiphospholipid Syndrome | Phase 3 | Status: UNKNOWN